Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more
Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Advances in using PARP inhibitors to treat cancer

  • Shivaani Kummar1,
  • Alice Chen1,
  • Ralph E Parchment2,
  • Robert J Kinders2,
  • Jay Ji2,
  • Joseph E Tomaszewski1 and
  • James H Doroshow1, 3Email author
BMC Medicine201210:25

https://doi.org/10.1186/1741-7015-10-25

Received: 2 November 2011

Accepted: 9 March 2012

Published: 9 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 Nov 2011 Submitted Original manuscript
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
9 Mar 2012 Editorially accepted
9 Mar 2012 Article published 10.1186/1741-7015-10-25

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Cancer Treatment and Diagnosis, National Cancer Institute
(2)
Applied/Developmental Research Directorate, Science Applications International Corporation-Frederick, Inc., National Cancer Institute at Frederick
(3)
Center for Cancer Research, National Cancer Institute

Advertisement